Fibromyalgia remains one of the most widely misunderstood chronic health conditions in modern medicine. Historically frustrating for patients to navigate, it is characterised by chronic, widespread pain across most—if not all—of the body, alongside a complex array of systemic sensory symptoms.
At Hunter Pain Specialists, our multidisciplinary team approaches fibromyalgia not as a localised issue of the muscles or soft tissues, but as a complex disorder of the central nervous system. By combining clinical symptom management with cutting-edge pharmacological research, our goal is to help patients regain physical function and unravel the mechanics behind their hypersensitivity.
Because fibromyalgia does not show up on routine X-rays, blood tests, or structural scans, establishing a clinical diagnosis requires ruling out alternative inflammatory, rheumatological, or structural disorders.
The diagnostic presentation involves tracking a cluster of core systemic symptoms that impact a patient's daily functional capacity:
To understand fibromyalgia, it is essential to look at the brain and spinal cord. Modern clinical science views fibromyalgia as a disorder of central pain processing.
Think of your central nervous system’s pain perception mechanism like a home thermostat. In a healthy individual, the thermostat is calibrated correctly. In a patient with fibromyalgia, the thermostat has been turned up too high.
Because the central nervous system is in a constant state of volume amplification (central sensitisation), the brain misinterprets ordinary sensory inputs—like touch, pressure, or movement—and amplifies them into severe, unmanageable pain signals.
A foundational aspect of managing fibromyalgia is recognising that symptoms fluctuate. Patients frequently experience periods where their baseline widespread pain and exhaustion spike drastically—a state clinically referred to as a flare.
Flares are highly individualised but are commonly triggered or exacerbated by:
Effective multi-modal management focuses on mapping out these individual triggers to create a tailored program. This strategy often balances gentle, low-impact exercise and anti-inflammatory nutritional support alongside targeted nerve medications (such as anti-epileptic or specific anti-depressant agents) to help lower the nervous system's baseline reactivity.
When traditional first-line pharmaceuticals fail to provide functional relief, clinical research offers crucial new pathways. Hunter Pain Specialists remains at the global forefront of exploring alternative, innovative therapies to modulate central nervous system sensitivity:
A/Prof Marc Russo and his research colleagues co-authored a comprehensive systematic review and meta-analysis published in the prestigious journal Pain Physician. Analysing 12 clinical studies involving over 1,200 patients, the research examined the impact of cannabinoids on fibromyalgia-related discomfort.
In another landmark paper published in PAIN—the world's leading journal for pain medicine—Dr. Russo initiated and led a narrative review investigating the neuro-protective capabilities of an old respiratory drug, Ambroxol.
Living with fibromyalgia means learning how to systematically recalibrate your body's pain responses. While a universal cure does not yet exist, a combination of precise diagnostic staging, pacing strategies, and emerging interventional research can provide profound symptom control.
If you are dealing with chronic, widespread pain that has resisted standard therapies, a specialised, multi-disciplinary consultation can help you rebuild your functional roadmap.
Talk to your General Practitioner about securing a formal referral to Hunter Pain Specialists. Contact our clinical intake desk today at (02) 4985 1800, or visit our contact page to begin your personalised care strategy.